Sunesis Pharmaceuticals reports second quarter 2016 financial results
Sunesis reported the loss from operations for the 2016 second quarter was $10.0 million. Revenue for the 2016 second quarter was $0.6 million versus $0.9 million for the same 2015 period. As of June 30, 2016, cash and equivalents totaled $33.1 million.
July 29, 2016